Han Ying, Ph.D.

Han Ying, Ph.D.

Senior Vice President, Science and Former Chief Executive OfficeratGyre Therapeutics· In proxies 2023–2025

Pay in FY2025-88% from the year before · Gyre Therapeutics stock -41.7% the same year

Han Ying, Ph.D. was paid $353.3K in FY2025 (Dec), down 88%. Gyre Therapeutics stock fell 41.7% that year.

Pay$100 in the stock at the end of FY23 → $27
Pay is from the Summary Compensation Table of each Gyre Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Gyre TherapeuticsPublic company · 3 yr
    • Senior Vice President, Science and Former Chief Executive Officer2023 – Present · 3 yrStock in role +49%
  2. Gene CorporationPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?